How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €416.50 | €500.91 |
| Amazon.com Inc. | €224.90 | €258.70 |
| Alphabet Inc. C | €294.55 | €367.50 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.32 | €91.19 |
| Western Union Co. | €6.22 | €6.07 |
| Socket Mobile Inc. | ? | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Tvardi Therapeutics Inc. | quelbe60 | 39.42% |
| B Western Digital Corp. | RudolfL | 10.44% |
| B Workday, Inc. | Wells Fargo & Company | 10.43% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Capricor Therapeutics Inc | Bankster | -22.55% |
| S Socket Mobile Inc. | blaugold | -18.52% |
| S H&R Block Inc. | The Goldman Sachs Group, Inc. | -14.28% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
OP Research
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Nu Skin Enterprises A
WKN: 903911 / Symbol: NUS / Name: Nu Skin Enter / Stock / Personal &Household Products & Services / Mid Cap /
Pros
Cons
Outlook Therapeutics Inc.
WKN: A4046T / Name: Outlook Therapeutics Inc. / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Carnival Paired Ctf | €23.45 | 5.850% |
| Discovery Communications C | €22.42 | 5.110% |
| Lam Research Corp. | €7,371.0 | 3.990% |
| Westrock Co | €47.53 | 3.930% |
| Bath & Body Works Inc. | €16.86 | 3.790% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Sandisk Corp. | €1,460.0 | -5.810% |
| Western Digital Corp. | €436.30 | -5.540% |
| Seagate Technology.Holdings plc | €816.00 | -5.120% |
| Marvell Technology Inc. | €192.42 | -4.980% |
| Lumentum Holdings Inc | €798.60 | -4.540% |
Courses
Key figures for stocks
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Nu Skin Enterprises A
09:02
08:32
Outlook Therapeutics Inc.
08:36
18.08.27
10:54
Ast Spacemobile Inc.
08:22
18.08.27
11:14
Top News
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301
Key Points
- Interested in Tenaya Therapeutics, Inc.? Here are five stocks we like better.
- Tenaya expects fourth-quarter updates on its TN-201 and TN-401 cardiac gene therapy programs, including
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline
Tonix Pharmaceuticals (NASDAQ:TNXP) is focusing its near-term strategy on the commercial launch of TONMYA for fibromyalgia while advancing
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Tandem is shifting U.S. pump distribution to pharmacies through a pay-as-you-go model designed to
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
Key Points
- Interested in TransMedics Group, Inc.? Here are five stocks we like better.
- Kidney transplantation is TransMedics’ largest growth initiative: The company estimates its OCS kidney
TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference
Key Points
- Interested in TriSalus Life Sciences, Inc.? Here are five stocks we like better.
- Commercial expansion is underway: TriSalus substantially enlarged its sales force, with new
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
For Immediate Release
Chicago, IL – August 18, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Gartner, Huron Consulting, CBIZ and Information Services
For Immediate Release
Chicago, IL – August 18, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Walmart, Home Depot, Target, Lowe's, Deere and JP Morgan
For Immediate Release
Chicago, IL – August 18, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights SKYY, WCLD, CLOU and FCLD
For Immediate Release
Chicago, IL – August 18, 2026 – Zacks.com announces the list of ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
The Zacks Analyst Blog Highlights Walt Disney, Parker-Hannifin and Occidental Petroleum
For Immediate Release
Chicago, IL – August 18, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
News
Gentherm Targets $3.5B Revenue as Modine Deal Expands Beyond Autos
Key Points
- Interested in Gentherm Inc? Here are five stocks we like better.
- Modine transaction: Gentherm expects its combination with Modine Performance Technologies to close in early Q4
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection
Key Points
- Interested in TG Therapeutics, Inc.? Here are five stocks we like better.
- 908 Devices is concentrating exclusively on handheld chemical and drug detection for public safety, law
Atlassian Conference Highlights AI-Led Cloud Growth, Expanding Enterprise Demand
Key Points
- Interested in Atlassian Corporation PLC? Here are five stocks we like better.
- AI is driving Atlassian’s cloud momentum: Customers are upgrading to the Teamwork Collection for
Yalla Group Q2 Earnings Call Highlights
Key Points
- Interested in Yalla Group Limited Sponsored ADR? Here are five stocks we like better.
- Q2 revenue exceeded guidance at $82.6 million, supported by an 11.6% increase in game-services
Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts
Key Points
- Interested in Stoke Therapeutics, Inc.? Here are five stocks we like better.
- Stoke Therapeutics’ Phase III EMPEROR trial for Dravet syndrome has enrolled 162 patients, surpassing
Q2 Earnings Season Standout Performers: PLTR, MSFT
The Q2 earnings season continues to wind down, which has overall shown immense strength with outsized growth. There have been several standout releases during the Q2 earnings cycle, including those
Contest
Still running
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.